Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Response to Licensed Influenza Vaccines in Adults 65-74 Years of Age
NCT02872311Completed
- Sponsor
- Marshfield Clinic Research Institute
- Start
- Sep 2016
- Primary completion
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of influenza vaccine (quadrivalent, high-dose), Fluzone Trivalent, influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (uv, formaldehyde inactivated) and influenza vaccine in influenza (5 arms), sponsored by Marshfield Clinic Research Institute. Primary endpoint: Hemagglutination Inhibition Titers. Started Sep 2016; status: completed.
02
Drugs
influenza vaccine (quadrivalent, high-dose)Fluzone Trivalentinfluenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (uv, formaldehyde inactivated)influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT02872311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02872311.